Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Femovan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
The alterations in lipid metabolism that occur with the use of oral contraceptives (OCs) have aroused considerable concern that… Expand
Is this relevant?
1994
1994
A cross-over study of two oral contraceptive formulations, containing 30 micrograms ethinylestradiol in combination with 150… Expand
Is this relevant?
1994
1994
31 women aged 26-35 were observed during hormonal contraception with Femovan (in Poland registered as Femoden). The aim of the… Expand
Is this relevant?
1992
1992
The serum concentrations of gestodene (CAS 60282-87-3) as well as the binding of this progestin to serum proteins were studied in… Expand
Is this relevant?
1992
1992
Two low-dose oral contraceptives, both containing the same dose of ethinyl estradiol (EE2, CAS 57-63-6) but different progestins… Expand
Is this relevant?
1991
1991
Gestoden ist als Kombinationspraparat mit Ethinylestradiol als orales Kontrazeptivum nach der Ersteinfuhrung in Deutschland 1987… Expand
Is this relevant?
1990
1990
Results from two clinical pharmacokinetic studies are given. The first study was an observational study in oral contraceptive… Expand
  • table I
  • table II
  • table III
  • table IV
  • figure 1
Is this relevant?
1990
1990
Oral contraception has proved to be the most efficient reversible method of fertility control for over 25 years. During this… Expand
Is this relevant?
1990
1990
The low dose oral contraceptive Femovan/Gynera which contains 0.03 mg Ethinylestradiol and 0.075 mg Gestoden was examined in… Expand
Is this relevant?
1988
1988
Primary dysmenorrhea occurs mostly in young women with a painful bleeding pattern. In a recent study, 72% of 19-year-old women… Expand
Is this relevant?